Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer

NCT00582582 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

OTHER

Sponsor class

Stopped Lack of drug supply for doxercalciferol for this study

Conditions

Prostate Cancer

Interventions

DRUG: Docetaxel plus doxercalciferol
DRUG: Docetaxel plus placebo

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]